6.
Porreca A, Noale M, Artibani W, Bassi P, Bertoni F, Bracarda S
. Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study. Health Qual Life Outcomes. 2018; 16(1):122.
PMC: 6001046.
DOI: 10.1186/s12955-018-0952-5.
View
7.
Lane A, Metcalfe C, Young G, Peters T, Blazeby J, Avery K
. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life. BJU Int. 2016; 118(6):869-879.
PMC: 5113698.
DOI: 10.1111/bju.13582.
View
8.
Shin D, Lee S, Kim T, Yun S, Nam J, Jeon S
. Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study. Cancer Res Treat. 2018; 51(2):556-567.
PMC: 6473266.
DOI: 10.4143/crt.2018.221.
View
9.
Cuypers M, Lamers R, Cornel E, van de Poll-Franse L, de Vries M, Kil P
. The impact of prostate cancer diagnosis and treatment decision-making on health-related quality of life before treatment onset. Support Care Cancer. 2017; 26(4):1297-1304.
PMC: 5847026.
DOI: 10.1007/s00520-017-3953-8.
View
10.
Huang W, Zhang Y, Shen B, Wang S, Meng H, Jin X
. Outcomes of health-related quality of life after open, laparoscopic, or robot-assisted radical prostatectomy in China. Cancer Manag Res. 2019; 11:899-907.
PMC: 6342140.
DOI: 10.2147/CMAR.S189893.
View
11.
Knowles K, Olatunji B
. Specificity of trait anxiety in anxiety and depression: Meta-analysis of the State-Trait Anxiety Inventory. Clin Psychol Rev. 2020; 82:101928.
PMC: 7680410.
DOI: 10.1016/j.cpr.2020.101928.
View
12.
Wald D, Casey-Gillman O, Comer K, Mansell J, Teo H, Mouyis K
. Animation-supported consent for urgent angiography and angioplasty: a service improvement initiative. Heart. 2020; 106(22):1747-1751.
PMC: 7656148.
DOI: 10.1136/heartjnl-2019-316227.
View
13.
Inglis S, Farnill D
. The effects of providing preoperative statistical anaesthetic-risk information. Anaesth Intensive Care. 1993; 21(6):799-805.
DOI: 10.1177/0310057X9302100609.
View
14.
Tominaga T, Matsushima M, Nagata T, Moriya A, Watanabe T, Nakano Y
. Psychological impact of lifestyle-related disease disclosure at general checkup: a prospective cohort study. BMC Fam Pract. 2015; 16:60.
PMC: 4437684.
DOI: 10.1186/s12875-015-0272-3.
View
15.
Kayhan F, Cicek E, Uguz F, Karababa I, Kucur R
. Mood and anxiety disorders among inpatients of a university hospital in Turkey. Gen Hosp Psychiatry. 2013; 35(4):417-22.
DOI: 10.1016/j.genhosppsych.2013.03.004.
View
16.
Chou R, Croswell J, Dana T, Bougatsos C, Blazina I, Fu R
. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011; 155(11):762-71.
DOI: 10.7326/0003-4819-155-11-201112060-00375.
View
17.
Ong W, Evans S, Spelman T, Kearns P, Murphy D, Millar J
. Comparison of oncological and health-related quality of life outcomes between open and robot-assisted radical prostatectomy for localised prostate cancer - findings from the population-based Victorian Prostate Cancer Registry. BJU Int. 2015; 118(4):563-9.
DOI: 10.1111/bju.13380.
View
18.
Pastore A, Mir A, Maruccia S, Palleschi G, Carbone A, Lopez C
. Psychological distress in patients undergoing surgery for urological cancer: A single centre cross-sectional study. Urol Oncol. 2017; 35(12):673.e1-673.e7.
DOI: 10.1016/j.urolonc.2017.08.006.
View
19.
Macefield R, Metcalfe C, Lane J, Donovan J, Avery K, Blazeby J
. Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. Br J Cancer. 2010; 102(9):1335-40.
PMC: 2865757.
DOI: 10.1038/sj.bjc.6605648.
View
20.
Mitchell A, Chan M, Bhatti H, Halton M, Grassi L, Johansen C
. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011; 12(2):160-74.
DOI: 10.1016/S1470-2045(11)70002-X.
View